Long Covid Newsletter
Issue #18January 5, 20267 studies

Long COVID patients face 40% higher healthcare costs

New research this week reveals the true financial burden of long COVID while offering hope through innovative treatment approaches. From healthcare spending patterns to breakthrough rehabilitation methods, here's what scientists are discovering about managing this persistent condition.

💰 Long COVID Patients Face 40% Higher Healthcare Costs

  • Long COVID patients spent an average of $11,567 on healthcare annually compared to $7,448 for those without the condition—a difference of more than $4,000 per person

  • After adjusting for age, insurance, and chronic conditions, long COVID patients still incurred 40% higher total healthcare expenditures

  • The biggest cost drivers were outpatient services (118% higher) and office-based visits (35% higher), while emergency room and hospital costs showed no significant difference

Why it matters: These numbers reveal long COVID's hidden economic impact—patients aren't necessarily sicker in dramatic ways requiring hospitalization, but they need substantially more ongoing care and specialist visits to manage persistent symptoms.

Key Findings

🏠 Virtual Physical Therapy Helps Long COVID Patients Recover

  • 13 women with long COVID completed an 8-week virtual rehabilitation program featuring tailored exercises and weekly educational sessions

  • Participants reported significant improvements in energy, mobility, and confidence, though some faced challenges returning to work

  • The program was praised for its convenient scheduling, supportive kinesiologists, and individualized exercise plans, though participants struggled to maintain progress without ongoing support

💡 Virtual rehabilitation may offer an accessible path to recovery, but patients need continued support to maintain their gains.
Top 30% journal 🔗 Archives of rehabilitation research and clinical translation Journal Article 🗓️ Jan 1

🧬 SGLT2 Diabetes Drugs May Prevent Long COVID Brain Symptoms

  • Type 2 diabetes patients taking SGLT2 inhibitors (common diabetes medications) showed protection against long COVID-associated cognitive problems and pain symptoms

  • The protective effects were specifically noted for neurological manifestations rather than other long COVID symptoms

  • The mechanism behind this protection remains unclear, but suggests these widely-used diabetes drugs may have broader applications

💡 Existing diabetes medications could potentially help prevent some of the most debilitating long COVID symptoms affecting the brain.
Top 20% journal 🔗 Virology journal Journal Article 🗓️ Dec 31

🔬 Female Mice Show Heart Inflammation 28 Days After COVID

  • Female mice infected with the Omicron variant showed significantly higher levels of inflammatory markers IL-6 and CD11d in heart tissue 28 days post-infection

  • The inflammation was characterized by sustained activation of chemokine-mediated signaling rather than severe tissue damage

  • No significant changes were found in markers of actual cardiac damage, suggesting persistent low-grade inflammation without structural harm

💡 Post-COVID heart problems in females may involve ongoing inflammation rather than direct tissue damage.
Top 20% journal 🔗 Viruses Journal Article 🗓️ Dec 31

📊 Long COVID Affects Over 18% of Survivors Long-Term

  • A meta-analysis of 14 studies involving 168,679 people found 18% of COVID survivors still had long COVID symptoms after 6+ months

  • Fatigue affected 41% of long COVID patients and breathing problems affected 22.5%—the two most common persistent symptoms

  • Women were 52% more likely to develop long COVID, and people who were hospitalized during acute COVID had 2.35 times higher risk

💡 Nearly 1 in 5 COVID survivors face persistent symptoms, with women and those with severe initial infections at highest risk.
Top 20% journal 🔗 Biomedicines Review 🗓️ Dec 30

🧠 Brain Scans Reveal Different Damage Patterns in Long COVID Subtypes

  • 76 long COVID patients showed distinct patterns of brain demyelination (protective coating loss) depending on whether they had insomnia, depression, or both

  • Insomnia patients had the most widespread brain changes affecting memory and attention pathways, while depression patients showed changes in emotion-processing regions

  • Blood levels of anti-PLP autoantibodies were highest in insomnia patients and correlated with both symptom persistence and brain changes

💡 Different long COVID symptoms may reflect distinct patterns of brain inflammation and damage.
Top 20% journal 🔗 International journal of molecular sciences Journal Article 🗓️ Dec 30

🏥 Norway Sees 7% Surge in Healthcare Visits Throughout 2024

  • Norway recorded 1.2 million excess primary care consultations in 2024—a 7.1% increase compared to pre-pandemic trends

  • The biggest increases were for fatigue (70% excess), psychological complaints (87% excess), and memory problems (63% excess)

  • Women aged 15-29 and young adults showed disproportionately large increases in consultations for memory disturbances

💡 Population-level health impacts from repeated COVID infections may be creating sustained pressure on healthcare systems.
Top 20% journal 🔗 Archives of public health = Archives belges de sante publique Journal Article 🗓️ Jan 4

Implications

This week's research paints a complex picture of long COVID's impact—it's expensive to treat, affects nearly 1 in 5 survivors, and may involve distinct brain changes depending on symptoms. However, virtual rehabilitation shows promise and existing diabetes drugs might offer unexpected protection, suggesting multiple pathways toward better management and prevention.

Studies in this issue

Primary sources used for this newsletter.

  1. Healthcare Costs in People With and Without Long COVID in the United States
    main storyInquiry : a journal of medical care organization, provision and financing2026-01-03PMID 41482843
  2. Views of People with Long COVID on Online Physical Rehabilitation
    key findingArchives of rehabilitation research and clinical translation2026-01-01PMID 41477078
  3. SGLT2 inhibitors may prevent long-COVID memory and pain problems in people with type 2 diabetes
    key findingVirology journal2025-12-31PMID 41476195
  4. Heart Tissue Damage and Inflammation Linked to Signaling Proteins in Female Animals After COVID
    key findingViruses2025-12-31PMID 41472298
  5. How Common Long COVID Is and What Increases Its Risk: A Review of Long-Term Studies
    key findingBiomedicines2025-12-30PMID 41462874
  6. Higher number of primary healthcare visits in Norway in 2024 compared to before the COVID-19 pandemic
    key findingArchives of public health = Archives belges de sante publique2026-01-04PMID 41484677
  7. Loss of Nerve Insulation and Thinking Skills in Long COVID Patients with Sleep Problems or Depression
    key findingInternational journal of molecular sciences2025-12-30PMID 41465566

Continue reading

All Long Covid issues